ARBOR BIOTECHNOLOGIES Trademark
Trademark Overview
On Friday, April 15, 2022, a trademark application was filed for ARBOR BIOTECHNOLOGIES with the United States Patent and Trademark Office. The USPTO has given the ARBOR BIOTECHNOLOGIES trademark a serial number of 97365239. The federal status of this trademark filing is EX PARTE APPEAL PENDING as of Wednesday, February 28, 2024. This trademark is owned by Arbor Biotechnologies, Inc.. The ARBOR BIOTECHNOLOGIES trademark is filed in the Treatment & Processing of Materials Services, Pharmaceutical Products, and Computer & Software Services & Scientific Services categories with the following description:
Manufacturing of pharmaceuticals, gene therapy products, and cell therapy products for others
Pharmaceutical preparations and therapeutic pharmaceuticals for the treatment of genetic diseases and disorders, genomic diseases and disorders, and cancer; gene therapy products, namely, genetically engineered DNA molecules and gene delivery pharmaceuticals for use in the treatment of genetic diseases and disorders, genomic diseases and disorders, and cancer; cell therapy products, namely, cells for medical and clinical use
Pharmaceutical research and development; research and development in the fields of gene therapy and cell therapy
General Information
| Serial Number | 97365239 |
| Word Mark | ARBOR BIOTECHNOLOGIES |
| Filing Date | Friday, April 15, 2022 |
| Status | 760 - EX PARTE APPEAL PENDING |
| Status Date | Wednesday, February 28, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | NOT AVAILABLE |
Trademark Statements
| Goods and Services | Manufacturing of pharmaceuticals, gene therapy products, and cell therapy products for others |
| Goods and Services | Pharmaceutical preparations and therapeutic pharmaceuticals for the treatment of genetic diseases and disorders, genomic diseases and disorders, and cancer; gene therapy products, namely, genetically engineered DNA molecules and gene delivery pharmaceuticals for use in the treatment of genetic diseases and disorders, genomic diseases and disorders, and cancer; cell therapy products, namely, cells for medical and clinical use |
| NOT AVAILABLE | "BIOTECHNOLOGIES" |
| Goods and Services | Pharmaceutical research and development; research and development in the fields of gene therapy and cell therapy |
Classification Information
| International Class | 040 - Treatment of materials. |
| US Class Codes | 100, 103, 106 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, August 4, 2023 |
| Primary Code | 040 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, April 20, 2022 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, April 20, 2022 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | Arbor Biotechnologies, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Cambridge, MA 02140 |
Trademark Events
| Event Date | Event Description |
| Wednesday, April 20, 2022 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Tuesday, April 19, 2022 | NEW APPLICATION ENTERED |
| Thursday, February 2, 2023 | ASSIGNED TO EXAMINER |
| Friday, February 3, 2023 | NON-FINAL ACTION WRITTEN |
| Friday, February 3, 2023 | NON-FINAL ACTION E-MAILED |
| Friday, February 3, 2023 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Tuesday, May 2, 2023 | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED |
| Tuesday, May 2, 2023 | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED |
| Thursday, August 3, 2023 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Thursday, August 3, 2023 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Friday, August 4, 2023 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Thursday, August 31, 2023 | FINAL REFUSAL WRITTEN |
| Thursday, August 31, 2023 | FINAL REFUSAL E-MAILED |
| Thursday, August 31, 2023 | NOTIFICATION OF FINAL REFUSAL EMAILED |
| Monday, November 27, 2023 | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED |
| Monday, November 27, 2023 | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED |
| Wednesday, February 28, 2024 | EXPARTE APPEAL RECEIVED AT TTAB |
| Wednesday, February 28, 2024 | EX PARTE APPEAL-INSTITUTED |
| Monday, November 4, 2024 | ASSIGNED TO EXAMINER |
| Monday, November 4, 2024 | ASSIGNED TO EXAMINER |
